Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization
NEJM Evidence · 27.05.2025 · 4 (6)
DOI: 10.1056/evidoa2500012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 27.05.2025. Verfasst von Cara A Flynn und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Lung Health, National Institute for Health and Care Research Leicester Biomedical Research Centre, University Hospitals of Leicester NH…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Lung Health, National Institute for Health and Care Research Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust and University of Leicester, UK.
- Leicester Clinical Trials Unit, College of Life Sciences, University of Leicester, UK.
Zitieren
APA
Flynn, C. A., McAuley, H. J. C., Elneima, O., Aung, H. W. W., Ibrahim, W., Ward, T. J. C., Bourne, M., Thornton, T. D., Mistry, V., Gilbert, H. R., Waheed, G., Wright, A. K. A., Evans, R. A., Steiner, M. C., Brookes, C. L., Brightling, C. E., & Greening, N. J. (2025). Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization. NEJM Evidence, 4(6). https://doi.org/10.1056/evidoa2500012
Vancouver
Flynn CA, McAuley HJC, Elneima O, Aung HWW, Ibrahim W, Ward TJC, et al. Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization. NEJM Evidence. 2025;4(6). doi:10.1056/evidoa2500012
BibTeX
@article{Flynn2025,
author = {Flynn, Cara A and McAuley, Hamish J C and Elneima, Omer and Aung, Hnin W W and Ibrahim, Wadah and Ward, Thomas J C and Bourne, Michelle and Thornton, Tracey D and Mistry, Vijay and Gilbert, Hannah R and Waheed, Ghazala and Wright, Adam K A and Evans, Rachel A and Steiner, Michael C and Brookes, Cassandra L and Brightling, Christopher E and Greening, Neil J},
title = {Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization},
journal = {NEJM Evidence},
year = {2025},
volume = {4},
number = {6},
doi = {10.1056/evidoa2500012}
}
EUVIMED